Precigen touts heart failure multigenic therapy results
Precigen is highlighting clinical results from a phase I trial conducted by its subsidiary Precigen Triple-Gene that show that its multigenic investigational therapeutic agent for heart failure improves patient outcomes. Read More
Cellect secures stem cell-based therapy patent
Cellect Biotechnology has secured a European patent for its stem cell selection technology. The patent was also approved in Australia and Israel, according to the firm. Read More
Amazon powers Moderna's digital biotech platform
Amazon Web Services is providing cloud, analytics, and machine-learning services to Moderna for its messenger RNA platform and manufacturing facility. Read More
Kriya establishes internal gene therapy manufacturing capacity
Kriya Therapeutics has secured a 51,000-sq-ft facility in Research Triangle Park, NC, to establish internal operational manufacturing of its pipeline of adeno-associated virus-based gene therapies. Read More
Elios' customized cancer vaccine shows positive results
Elios Therapeutics' personalized cancer vaccine shows a long-term survival benefit for patients with stage III or IV melanoma, according to final data from its clinical trial. Read More
J&J to provide U.S. with 100M doses of COVID-19 vaccine
Johnson & Johnson will manufacture and deliver 100 million doses of its SARS-CoV-2 investigational vaccine to the U.S. government once it receives regulatory approval from the U.S. Food and Drug Administration. Read More
Celularity begins trial of COVID-19 cell therapy
Celularity has received funding to support a phase I/II clinical trial of human placental hematopoietic stem cell-derived natural killer cells for the treatment of COVID-19. Read More
Taysha gets $95M in financing to advance gene therapies
Taysha Gene Therapies has closed on $95 million in series B financing to advance gene therapies for monogenic central nervous system diseases. Read More
ANA Therapeutics to begin clinical trial for COVID-19 treatment
ANA Therapeutics said that the U.S. Food and Drug Administration has cleared its investigational new drug application for ANA001 (niclosamide capsules) as a potential COVID-19 treatment. Read More
Bio-Rad wins appeal in 10x Genomics patent infringement ruling
Bio-Rad Laboratories said that the U.S. Court of Appeals for the Federal Circuit has affirmed a lower court ruling that 10x Genomics had willfully infringed a patent that had been exclusively licensed to Bio-Rad by the University of Chicago. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
